Patient-Derived Tumour Organoids (PDOs) may help oncologists in clinical practice
{{output}}
The use of cancer organoids represents a major advancement in oncology research, addressing the limitations of traditional 2D cell cultures. Optimized protocols now allow the generation of organoids from a wide range of tumor types, including breast, skin, lun... ...